XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2023
Shareholders' Equity  
Summary of share option activity

A summary of share option activity is set forth below (in thousands except per share amounts and years):

OUTSTANDING AWARDS

NUMBER

WEIGHTED-

OF

NUMBER OF

AVERAGE

SHARES

SHARES

WEIGHTED-

REMAINING

AVAILABLE

UNDERLYING

AVERAGE

CONTRACTUAL

AGGREGATE

FOR

OUTSTANDING

EXERCISE

TERM

INTRINSIC

    

GRANT

    

OPTIONS

    

PRICE

    

(IN YEARS)

    

VALUE

As of December 31, 2022

 

977

 

7,612

$

1.62

 

8.57

$

13,283

Additional shares authorized

12,000

Granted

 

(4,760)

 

4,760

5.79

 

  

 

  

Exercised

 

 

(94)

2.22

 

  

 

  

Forfeited

 

236

 

(236)

2.83

 

  

 

  

As of June 30, 2023

 

8,453

 

12,042

3.24

 

8.67

 

127,869

Exercisable at June 30, 2023

 

3,248

1.23

 

7.71

 

41,028

Vested and expected to vest at June 30, 2023

 

12,042

3.24

 

8.67

 

127,869

Summary of restricted shares activity

Activity with respect to restricted shares was as follows (in thousands, except per share amounts):

    

    

NUMBER OF SHARES

UNDERLYING

WEIGHTED-

OUTSTANDING

AVERAGE

RESTRICTED

GRANT DATE FAIR

    

SHARES

    

VALUE

Unvested, December 31, 2022

327

$

0.33

Vested

(327)

0.33

Unvested, June 30, 2023

 

 

Schedule of recognized share-based compensation

The Company recognized share-based compensation as follows (in thousands):

    

    

    

THREE MONTHS ENDED

SIX MONTHS ENDED

JUNE 30, 

JUNE 30, 

 

2023

    

2022

 

2023

    

2022

 

Research and development

$

584

$

232

$

2,176

$

491

General and administrative

 

1,118

 

411

 

2,059

 

772

Total share-based compensation

$

1,702

$

643

$

4,235

$

1,263